{"id":52764,"date":"2023-01-10T17:02:18","date_gmt":"2023-01-10T16:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/"},"modified":"2023-01-10T17:02:18","modified_gmt":"2023-01-10T16:02:18","slug":"scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/","title":{"rendered":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>First-of-its-kind technology stack in autoimmune diseases.<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<i>Provides unprecedented insights into optimal patient treatment pathway.<\/i>\n<\/p>\n<p>WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fsciphermedicine.com%2F&amp;esheet=53193640&amp;newsitemid=20230110005763&amp;lan=en-US&amp;anchor=Scipher+Medicine&amp;index=1&amp;md5=d145a56cc0d5eb31667f216248cd25cb\" rel=\"nofollow noopener\" shape=\"rect\">Scipher<b> <\/b>Medicine<\/a>, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/5\/Scipher_Corporate.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg\"><\/a><\/p>\n<p>\nThe acquisition gives Scipher new data management and analytics capabilities to enable a more granular and real-time understanding of patients\u2019 treatment pathway. CrossBridge\u2019s SaaS value-based care platform bridges gaps between patients, providers, payers, and improves health outcomes and lowers the cost of care for autoimmune disease patients. The transaction has closed, and terms were not disclosed.\n<\/p>\n<p>\n<b>\u201c<\/b>There is a significant need to better understand how and when to apply various therapeutic and diagnostic interventions to improve the treatment pathway for patients,\u201d said Scipher\u2019s Chief Executive Officer Alif Saleh. \u201cTo date, we have not had a platform combining critical patient molecular, clinical and claims data as autoimmune diseases, including rheumatoid arthritis.\n<\/p>\n<p>\n\u201cThe addition of CrossBridge will accelerate our growth and advance our mission to match each patient with their most effective therapy while creating seamless EMR integration and efficiencies for healthcare systems and payers,\u201d added Saleh. \u201cThe acquisition allows us to collect and map clinical data and outcomes over time to better track the evolution of patient health and the value of healthcare interventions including blood-based therapy selection tests such as PrismRA.\u201d\n<\/p>\n<p>\nPrismRA is a revolutionary blood test bringing precision medicine to the treatment of rheumatoid arthritis, which affects 20 million patients globally. From a routine blood draw, the PrismRA test analyzes an individual\u2019s molecular signature, helping identify who is unlikely to adequately respond to TNFI therapy, the world\u2019s largest selling drug class, so non-responders can be prescribed alternative effective therapy and avoid unnecessary dose escalations or drug cycles.\n<\/p>\n<p>\n\u201cWe are excited to contribute to the vital innovation that Scipher has pioneered for millions of patients, and we are glad to see our data analytics capabilities used to deliver value to patients, providers and payers,\u201d said CrossBridge Founder Bill Conlan.\n<\/p>\n<p>\n\u201cThis acquisition is an exciting milestone and a key part of our growth strategy,\u201d Saleh said. \u201cOne of our goals is to disrupt systemic inefficiencies in healthcare, and CrossBridge will help us realize that vision.\u201d\n<\/p>\n<p>\n<b>About Scipher<\/b>\n<\/p>\n<p>\nScipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectra\u2122, our proprietary network medicine platform, we commercialize tests revealing a person\u2019s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sciphermedicine.com%2F&amp;esheet=53193640&amp;newsitemid=20230110005763&amp;lan=en-US&amp;anchor=sciphermedicine.com&amp;index=2&amp;md5=69ac9fa926e3ca6845cd50f7a18b8faf\" rel=\"nofollow noopener\" shape=\"rect\">sciphermedicine.com<\/a> and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Relations<\/b><br \/>Corporate Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;lt&#x6f;&#x3a;&#80;&#82;&#64;&#x53;&#x63;&#105;&#112;h&#x65;&#x72;&#x2e;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#80;&#x52;&#x40;S&#99;&#x69;p&#104;&#x65;&#x72;&#46;&#99;&#x6f;m<\/a>\n<\/p>\n<p>\n<b>Investor Relations<\/b><br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;I&#82;&#x40;&#115;&#x63;i&#112;&#x68;e&#x72;&#46;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x49;&#82;&#64;s&#x63;&#x69;&#112;h&#x65;&#x72;&#46;co&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>First-of-its-kind technology stack in autoimmune diseases. Provides unprecedented insights into optimal patient treatment pathway. WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities. The acquisition gives Scipher new data management and analytics &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52764","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"First-of-its-kind technology stack in autoimmune diseases. Provides unprecedented insights into optimal patient treatment pathway. WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities. The acquisition gives Scipher new data management and analytics ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-10T16:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time\",\"datePublished\":\"2023-01-10T16:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/\"},\"wordCount\":522,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005763\\\/en\\\/1681976\\\/21\\\/Scipher_Corporate.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/\",\"name\":\"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005763\\\/en\\\/1681976\\\/21\\\/Scipher_Corporate.jpg\",\"datePublished\":\"2023-01-10T16:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005763\\\/en\\\/1681976\\\/21\\\/Scipher_Corporate.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230110005763\\\/en\\\/1681976\\\/21\\\/Scipher_Corporate.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/","og_locale":"en_US","og_type":"article","og_title":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend","og_description":"First-of-its-kind technology stack in autoimmune diseases. Provides unprecedented insights into optimal patient treatment pathway. WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, has acquired Philadelphia-based data, analytics, and software company CrossBridge to bolster its data and analytics capabilities. The acquisition gives Scipher new data management and analytics ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-10T16:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time","datePublished":"2023-01-10T16:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/"},"wordCount":522,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/","url":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/","name":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg","datePublished":"2023-01-10T16:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230110005763\/en\/1681976\/21\/Scipher_Corporate.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/scipher-medicine-acquires-crossbridge-and-its-saas-platform-to-collect-and-map-patient-molecular-outcomes-and-claims-data-in-real-time\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52764"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52764\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}